Paving the Path for
Webinar with LIVE Q&A
June 16, 2022
View more masterclass webinarsOn Demand
45 min + Q&A
Mohamed El-Mogy, M.Sc, Ph.D - Director of R&D Services
Michelle Stopher - Key Account Manager
Liquid biopsy samples are increasingly becoming one of the most valuable, minimally-invasive sources of information as the basis of diagnosis and disease monitoring as well as disease prevention. Biospecimens such as plasma, serum and urine contain various biomarkers that provide key insights into changes within the genome, epigenome, transcriptome and proteome of a patient. Next Generation Sequencing (NGS) is an extraordinary tool enabling researchers to dive deeper into the contents of liquid biopsy samples to advance discoveries in the fields of cancer research and complex disease genomics. In this webinar, we will discuss the various Next Generation Sequencing applications that can be explored which allow researchers to analyze the circulating analytes contained within liquid biopsy samples. We will focus a spotlight on Small (micro) RNA-Sequencing from cell-free RNA and RNA derived from exosomes, as an application for biomarker discovery and understanding cell to cell communication. We will also discuss the emerging field of transcriptome sequencing from cell-free RNA in liquid biopsy samples, the challenges of library preparation, and the immense potential of profiling circulating transcripts.
Dr. Mohamed El-Mogy is the Director of R&D Services at Norgen Biotek and has been with Norgen for over 12 years. Dr. El-Mogy’s background is in cell and molecular biology with an extensive focus in sample preparation and NGS applications. He oversees Norgen’s Research and Development pipelines and also acts as a Senior Research Scientist for Norgen’s Next Generation Sequencing and Molecular Diagnostic Services. Dr. El-Mogy plays an instrumental role in the continual evolution of Norgen’s laboratory services and advancements in science.
Michelle is a Key Account Manager for Norgen’s Next Generation Sequencing Services and has been working closely with some of the largest, most influential research institutions and companies for over 5 years at Norgen. Michelle holds an Honours Bachelor Science in Cell and Molecular Biology from University of Toronto and her experience lends to her extensive knowledge of Norgen’s liquid biopsy portfolio. She strives to ensure that Norgen provides comprehensive NGS solutions for even the most challenging of sample types.
We are excited to offer new webinars in our MasterClass series. Sign up to be the first to get all of the details!
May 18, 2022
April 13, 2022
45 min + Q&A
February 16, 2022
45 min + Q&A